Today’s show rundown:
Short Telomeres in relation to COVID 19 Jeff talks more about telomeres and where you can find info Mark introduces today's guest Dr. Dayan Goodenowe Dr. Goodenowe talks a little about what he does and how he got started Function and Disease can not co-exist LDL & HDL functions in the brain Cholesterol and mortality rates We're still stuck in old thinking Dementia and mortality rate
https://drgoodenowe.com/ https://drgoodenowe.com/breaking-alzheimers/ https://drgoodenowe.com/plasmalogens/ https://drgoodenowe.com/get-certified/
Dr. Goodenowe’s research into the biochemical mechanisms of disease started in 1990. His curiosity about the biochemistry of life is as insatiable today as it was 30 years ago. In those 30 years, Dr. Goodenowe invented and developed advanced diagnostic and bioinformatic technologies, designed and manufactured novel and natural biochemical precursors, and identified biochemical prodromes of numerous diseases including Alzheimer’s disease and dementia, Parkinson’s disease, multiple sclerosis, stroke, autism, amyotrophic lateral sclerosis (ALS), schizophrenia, bipolar disorder, depression, and cancers of the colon, pancreas, ovary, breast, lung, kidney, liver, stomach, and others. And he is just getting warmed up. Dr. Goodenowe is now going beyond disease and the detection of biochemical dysfunctions to diagnose and the correction of biochemical dysfunctions to treat disease. Dr. Goodenowe’s new focus is to defeat the entropy of aging by creating strategic biochemical and bio-functional reserve capacity in advance of known disease risks such that the human body can maintain the physical and biological functions of life indefinitely and without disease.
